Altium International is pleased to announce a new partnership with PepGel, an innovative biotechnology company specializing in synthetic peptide hydrogel technologies for advanced 3D cell culture and regenerative research.
PepGel’s proprietary PGmatrix™ platform enables the creation of physiologically relevant, fully synthetic, and animal-free microenvironments that closely mimic the native extracellular matrix (ECM). This allows cells to grow, organize, and function in true 3D structures, supporting applications such as organoid development, stem cell research, drug discovery, bioprinting, and in vivo delivery.
The PepGel portfolio includes dedicated platforms for:
- 3D cell culture – enabling formation of complex, in vivo–like cellular structures
- Stem cell expansion and differentiation – supporting robust and reproducible stem cell workflows
- 3D bioprinting (bioinks) – providing highly cytocompatible materials for precise tissue fabrication
- In vivo delivery – facilitating minimally invasive administration of cells and biologics
With fully defined, xeno-free compositions and tunable mechanical properties, PepGel solutions offer high reproducibility and flexibility, addressing key challenges associated with traditional biological matrices.
Through this partnership, Altium International expands its portfolio, providing research laboratories with access to next-generation 3D cell culture technologies that enable more predictive, reliable, and translationally relevant results.
For more information about PepGel solutions, feel free to contact us at [email protected].
